Safety agency makes better use of anticoagulants its top priorityBMJ 2007; 334 doi: http://dx.doi.org/10.1136/bmj.39170.698356.DB (Published 05 April 2007) Cite this as: BMJ 2007;334:714
- Lynn Eaton
Measures to reduce the risk of wrongly administering epidural infusions intravenously and better guidance for patients about anticoagulant drugs are among a series of risk management measures outlined this week to improve patient safety in the NHS.
The guidance from the National Patient Safety Agency comes after a number of avoidable deaths relating to the use of these and other drugs. Keith Ridge, the chief pharmaceutical officer for England, said that awareness of the importance of reducing weaknesses within healthcare systems was increasing.
The highest priority for the agency is the number of deaths associated with the use of anticoagulant drugs, such as warfarin, he said. In 2006 alone there were 120 deaths and 480 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial